;
Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Anatara completes IPO

    Anatara Lifesciences Ltd. (ASX:ANR), Brisbane, Australia Business: Gastrointestinal, Infectious, Veterinary Date completed: 2014-10-07 Type: IPO Raised: A$7 million ($6.1 million) Shares: 14 million Price: A$0.50 Shares…

    Published on 10/20/2014
  • Astute completes venture financing

    Astute Medical Inc., San Diego, Calif. Business: Diagnostic Date completed: 2014-10-09 Type: Venture financing Raised: Not disclosed Investor: CRG Note: The company received an undisclosed portion of a $30 million loan.…

    Published on 10/20/2014
  • Atara Biotherapeutics completes IPO

    Atara Biotherapeutics Inc. (NASDAQ:ATRA), Brisbane, Calif. Business: Cancer, Renal Date completed: 2014-10-15 Type: IPO Raised: $55 million Shares: 5 million Price: $11 Shares after offering: 19.4 million Underwriters: …

    Published on 10/20/2014
  • Bicycle Therapeutics completes venture financing

    Bicycle Therapeutics Ltd., Cambridge, U.K. Business: Chemistry, Cancer, Ophthalmic Date completed: 2014-10-14 Type: Venture financing Raised: Not disclosed Investors: Atlas Ventures; Novartis Venture Funds; SR One; SV …

    Published on 10/20/2014
  • ContraVir Pharmaceuticals completes private placement of convertible preferred stock

    ContraVir Pharmaceuticals Inc. (OTCBB:CTRV), New York, N.Y. Business: Infectious Date completed: 2014-10-15 Type: Private placement of convertible preferred stock Raised: $9 million Shares: 900,000 Price: $10 Shares …

    Published on 10/20/2014
  • Cytori completes direct public offering

    Cytori Therapeutics Inc. (NASDAQ:CYTX; Xetra:XMPA), San Diego, Calif. Business: Gene/Cell therapy, Musculoskeletal Date completed: 2014-10-10 Type: Direct public offering Raised: $13.5 million Units: 13,500 Price: $1,…

    Published on 10/20/2014
  • DiaGenic completes private placement

    DiaGenic ASA (OSE:DIAG), Oslo, Norway Business: Diagnostic Date completed: 2014-10-10 Type: Private placement Raised: NOK35 million ($5.4 million) Shares: 53.8 million Price: NOK0.65 Shares after offering: 285.1 million

    Published on 10/20/2014
  • DNAtrix completes venture financing

    DNAtrix Inc., Houston, Texas Business: Cancer Date completed: 2014-10-14 Type: Venture financing Raised: $20 million Investors: Morningside Group; Mercury Fund; Targeted Technology Fund; and other investors

    Published on 10/20/2014
  • Esperion completes follow-on

    Esperion Therapeutics Inc. (NASDAQ:ESPR), Plymouth, Mich. Business: Endocrine/Metabolic, Cardiovascular Date completed: 2014-10-15 Type: Follow-on Raised: $85 million Shares: 4.3 million Price: $20 Shares after offering…

    Published on 10/20/2014
  • Forward Pharma completes IPO

    Forward Pharma A/S (NASDAQ:FWP), Copenhagen, Denmark Business: Autoimmune Date completed: 2014-10-15 Type: IPO Raised: $220.5 million Shares: 10.5 million Price: $21 Shares after offering: 45.8 million Underwriters: …

    Published on 10/20/2014
  • Highland Therapeutics completes venture financing

    Highland Therapeutics Inc., Toronto, Ontario Business: Drug delivery Date completed: 2014-10-16 Type: Venture financing Raised: $25 million Investor: Not disclosed Note: The company said it sold class A common shares in…

    Published on 10/20/2014
  • Invitae completes venture financing

    Invitae Corp., San Francisco, Calif. Business: Diagnostic Date completed: 2014-10-13 Type: Venture financing Raised: $120 million Placement agent: JPMorgan Investors: Decheng Capital; Deerfield Management; OrbiMed …

    Published on 10/20/2014
  • Portal Instruments completes venture financing

    Portal Instruments Inc., Cambridge, Mass. Business: Drug delivery Date completed: 2014-10-15 Type: Venture financing Raised: $11 million Investors: Sanofi; PBJ Capital; and an undisclosed investor

    Published on 10/20/2014
  • Raze Therapeutics completes venture financing

    Raze Therapeutics Inc., Cambridge, Mass. Business: Cancer Date completed: 2014-10-14 Type: Venture financing Raised: $24 million Investors: Atlas Ventures; MPM Capital; MS Ventures; Partners Innovation Fund; Astellas …

    Published on 10/20/2014
  • Rigontec completes venture financing

    Rigontec GmbH, Bonn, Germany Business: Cancer, Infectious Date completed: 2014-10-14 Type: Venture financing Raised: EUR9.5 million ($12 million) Investors: Wellington Partners; Boehringer Ingelheim Venture Fund; NRW.…

    Published on 10/20/2014
  • Rockwell Medical completes warrant exercise

    Rockwell Medical Inc. (NASDAQ:RMTI), Wixom, Mich. Business: Renal, Hematology Date completed: 2014-10-07 Type: Warrant exercise Raised: $8 million Shares: 838,071 Price: $9.55 Shares after offering: 41.7 million …

    Published on 10/20/2014
  • Synthetic Biologics completes direct public offering

    Synthetic Biologics Inc. (NYSE-M:SYN), Rockville, Md. Business: Infectious, Autoimmune, Gastrointestinal Date completed: 2014-10-10 Type: Direct public offering Raised: $20.7 million Units: 14.1 million Price: $1.47 (…

    Published on 10/20/2014
  • Tetra Discovery completes venture financing

    Tetra Discovery Partners LLC, Grand Rapids, Mich. Business: Neurology Date completed: 2014-10-16 Type: Venture financing Raised: Not disclosed Investors: Grand Angels; Johnson & Johnson Development Corp. Note: The …

    Published on 10/20/2014
  • Tetraphase completes follow-on

    Tetraphase Pharmaceuticals Inc. (NASDAQ:TTPH), Watertown, Mass. Business: Infectious Date completed: 2014-10-16 Type: Follow-on Raised: $75.1 million Shares: 4 million Price: $19 Shares after offering: 30 million …

    Published on 10/20/2014
  • Unilife completes debt financing

    Unilife Corp. (NASDAQ:UNIS; ASX:UNS), York, Pa. Business: Drug delivery Date completed: 2014-10-03 Type: Debt financing Raised: $10 million Investor: OrbiMed Advisors Note: Unilife received $10 million in a second …

    Published on 10/20/2014
  • Zynerba completes venture financing

    Zynerba Pharmaceuticals Inc., Radnor, Pa. Business: Autoimmune, Neurology, Drug delivery Date completed: 2014-10-15 Type: Venture financing Raised: $13 million Investor: Perceptive Advisors

    Published on 10/20/2014
  • Canaan Partners financial update

    Canaan Partners, Menlo Park, Calif. Business: Finance Date announced: 2014-10-16 Note: Canaan Partners closed its tenth fund, Canaan X, with $675 million. The firm expects to invest about a third of the fund, or $225 …

    Published on 10/20/2014
  • Dyadic International financial update

    Dyadic International Inc. (OTCQX:DYAI), Jupiter, Fla. Business: Genomics, Supply/Service, Biomanufacturing Date announced: 2014-10-10 Note: Dyadic withdrew its Form 10 filing with the SEC to avoid it becoming effective …

    Published on 10/20/2014
  • iBio financial update

    iBio Inc. (NYSE-M:IBIO), Newark, Del. Business: Infectious Date announced: 2014-08-25 Note: iBio entered into a two-year stock purchase agreement with Aspire Capital for up to $10 million.

    Published on 10/20/2014
  • Nextech Invest financial update

    Nextech Invest, Zurich, Switzerland Business: Finance Date announced: 2014-10-14 Note: Nextech Invest raised the first $40 million of its planned $100 million Oncology IV fund, which it expects to close in the next 12 …

    Published on 10/20/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993